Related Experiment Video
Updated: May 7, 2026

06:43
In Vivo Proximity Biotinylation for Protein Interaction Studies in Paramecium tetraurelia
Published on: September 12, 2025
1.3K
Triazole biotin: a tight-binding biotinidase-resistant conjugate
Anne I Germeroth1, Jill R Hanna, Rehana Karim
1EaStCHEM School of Chemistry, University of Edinburgh, West Mains Road, Edinburgh, EH9 3JJ, UK. Alison.Hulme@ed.ac.uk.
Organic & Biomolecular Chemistry
|October 11, 2013
Summary
Researchers replaced the natural amide bond in biotin with a stable triazole linkage. This modification creates biotinidase-resistant biotin and enhances binding to avidin, useful for developing new biotin-based agents.
Area of Science:
- Bioconjugation Chemistry
- Protein Labeling
- Biomaterials Science
Background:
- The amide bond in biotinylated proteins is susceptible to hydrolysis by biotinidase.
- This susceptibility limits the stability and application of biotin-based detection and imaging systems.
- Developing robust biotin analogs is crucial for advanced biochemical assays and diagnostics.
Purpose of the Study:
- To engineer a novel biotinylation strategy resistant to biotinidase.
- To create stable triazole-linked biotin adducts with high avidin affinity.
- To demonstrate the utility of this strategy in developing diagnostic contrast agents.
Main Methods:
- Copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) reaction was employed.
- An alkynyl biotin derivative was reacted with an azide-containing molecule.
- The resulting triazole-linked biotin adducts were characterized for stability and binding affinity.
Main Results:
- Triazole-linked biotin adducts exhibited high resistance to biotinidase hydrolysis.
- Dissociation constants for avidin binding were in the low picomolar (pM) range, indicating strong affinity.
- Biotinidase-resistant biotin-Gd-DOTA contrast agents were successfully synthesized.
Conclusions:
- Replacing the amide bond with a triazole linkage provides robust biotinidase resistance.
- This strategy offers a valuable tool for creating stable biotinylated biomolecules.
- The developed biotinidase-resistant agents show promise for diagnostic imaging applications.
Related Concept Videos
Drug Biotransformation: Overview
3.7K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.7K
Drug Biotransformation: Overview
6.8K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
6.8K
Cofactors and Coenzymes
78.3K
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
78.3K

